Quality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

Similar documents
EU and FDA GMP Regulations: Overview and Comparison

Quality Agreements and Managing Contract Supplier Quality

How Pharma Should Monitor itself for GMP Compliance & How FDA Inspections Could Incorporate Pharmaceutical Inspection Cooperation Scheme (PIC/S)

GMP On Site Series. GMP Essentials

Christian Gausepohl, Frank Böttcher. GMP Focus. Managing Contract Manufacturers and Testing Labs. PDF Download. Excerpt from the GMP MANUAL

Inspections, Compliance, Enforcement, and Criminal Investigations

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Regional GMP Strengthening Workshop for Indian Pharmaceutical Manufacturers and State Regulators

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

Revision of Chapter 7 Contract Manufacture and Analysis

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

Q10 PHARMACEUTICAL QUALITY SYSTEM

GMP In-house Training

KINGSMANN CARE GROUP

Textvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf

Reference Standard Characterization. Steve Lane. General Manager, NSF Reference Standards.

PCI Pharmaceutical Consulting

GOOD TRADE AND DISTRIBUTION PRACTICES FOR PHARMACEUTICAL STARTING MATERIALS. REVISION

Q&A on ICH Q7 Good Manufacturing Practice Questions and Answers Document

A.1 Contents file 4 to 5 A.1 (1)

HACCP audit checklist

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

Quality Systems. Indian Pharmaceutical Alliance. Advanced GMP Workshops 2017

Responding to an FDA 483

GMPs: Distribution Centers

Guidance for Industry Process Validation: General Principles and Practices. F. Hoffman-La Roche, Ltd.

Developing a Robust Quality System to Assure Data Integrity

The Impact of Quality Culture on Quality Risk Management. FDA Perspective on Quality Culture; how it Impacts Risk Management

Pre-Approval Inspections for Drug Products

Good Distribution Practice and Supply Chain Risk Evaluation

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

GDP for APIs New Regulations. we prove it. The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle

Device: Good Manufacturing Practices Manual

Trinity College Dublin QP Forum 2017 Tuesday 25 th April

Safeguarding public health. Deficiency Database Figures April June 2009

Good Manufacturing Practice for Investigational Medicinal Products

Received: ; Accepted: ESSENTIALS OF QUALITY ASSURANCE

Annex 6. Good trade and distribution practices for pharmaceutical starting materials

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Continuous Pharmaceutical Manufacturing: CGMP, Process Validation, and Inspectional Considerations for Implementation

Questionnaire Layout:

GxP Auditing, Remediation, and Staff Augmentation

GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART I

Overview of Good Food Laboratory Practices

Quality Assurance Policy and Procedures

GCP Basics - refresher

Industry Perspective on Manufacturing in Early Development

GUIDELINES ON GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS PART 1

Annex 14 WHO guidelines for drafting a site master file 136

Chapter 8 Contract Manufacture and Contract Analysis

UNICEF Requirements for RUTF Manufacturers

Your partner in the pharmaceutical industry

Regulatory Expectations, Standards & Guidelines

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

Guidelines for Process Validation of Pharmaceutical Dosage Forms

GxP Auditing, Remediation, and Quality System Resourcing

PIC/S GUIDE TO GOOD PRACTICES FOR THE PREPARATION OF MEDICINAL PRODUCTS IN HEALTHCARE ESTABLISHMENTS

Int. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries

GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS

Combination Products Part 4 Compliance and Implementation at multi-site Network

MEASURE FOR MEASURE: QUALITY METRICS

UNICEF Quality Assurance in the procurement of medicines

GMP MANUAL Contents. Contents (1) 1 Pharmaceutical Quality System (PQS) 2 Personnel

AAMI Quality Systems White Paper: Comparison of 21 CFR Part 820 to ISO 13485:2016 1

Implementing Compliant Medical Device Best Practice Business Processes Using Oracle E-Business Suite

Vince Anicetti EVP Quality and Compliance, Coherus Biosciences West Coast PDA 20 October 2016

21 CFR Ch. I ( Edition) Personnel Design controls Identification Traceability.

Investigating OOS for Finished Product on the Stability Program. Presented by: Nicole Chang, QA Manager, Apotex Pty Ltd

NSF International Standard / American National Standard. NSF/IPEC/ANSI Good Manufacturing Practices (GMP) for Pharmaceutical Excipients

GxP Auditing, Remediation, and Staff Augmentation

PROPOSAL FOR REVISION OF THE SUPPLEMENTARY GUIDELINES ON GOOD MANUFACTURING PRACTICES: VALIDATION, APPENDIX 7:NON-STERILE PROCESS VALIDATION

LEARNING, TRAINING, AND PERFORMANCE

The interface between Good Clinical Practice and Good Manufacturing Practice

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

Standard operating procedures revisited: a 2014 perspective

Guidance for Industry

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: May 2017, Budapest, Hungary LEARNING OBJECTIVES:

FDA Perspective on Plasma Quality and GMPs

Good Documentation Practice (Gap): Coordinate Regulatory Requirements in Pharmaceutical Manufacturing Industry

18.H Questionnaire for preparing GMP-inspections

INS QA Programme Requirements

Global Compliance Trends and Warning Letters

Overview of FDA Regulations and Guidance Documents related to PET Drug Chemistry. Steve Zigler, Ph.D. Siemens PETNET Solutions

OOS: Back to Basics. Compliant, Effective, Efficient PATH

Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.

Laboratory OOS Investigations The Missing Link

FDA 21 CFR Part 820 vs. ISO 13485:2016 Comparison Table created by greenlight.guru

ICH Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management

Correspondence Between ISO 13485:2016 and 21 CFR Part 820 QMS Requirements

An is all it takes to change the way you work..!

Food and Drug Administration, HHS Pt Sec Scope Definitions Quality system.

Available online at ScienceDirect. Procedia Engineering 132 (2015 )

Enhanced Quality Product Documentation

PRAXIS. A publication by Bioengineering AG

Human Research Protection Program Good Clinical Practice Guidance for Investigators Regulatory File Essential Documents

OCTC 2012 CRO Selection

MHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents

Software Quality Regulatory Trends

Transcription:

Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals

FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality Agreements, Draft Guidance, May 2013

FDA Guidance Delineates responsibilities between CMO and client for API, finished drug product, combination products and biologicals 3

FDA Guidance Does not apply to Type A medicated articles and medicated feeds, medical devices, dietary supplements, and human tissue intended for transplantation.

FDA Guidance Applies to commercial manufacturing. Manufacturing includes processing, packing, holding, labeling, testing, and operations of the quality unit.

Definitions Owner = contract giver or client Contracted Facility = contract acceptor or contractor

Responsibilities Owner is responsible for assuring product introduced into interstate commerce is not adulterated or misbranded. Responsible for final product release. (can t be delegated!) See also 211.22(a) Contract Facility is responsible for compliance to cgmps.

Pop Quiz Does this mean that the contracted facility is not responsible for adulteration or misbranding?

Answer No, because the contractor is considered an extension of the owner. Both owner and contractor are responsible.

21 CFR Part 211.22(d) States that the responsibilities of the quality unit must be in writing

21 CFR Part 820.50 Purchasing Controls - each manufacturer shall establish and maintain quality requirements that must be met by supplier, contractors, and consultants.

ICH Guidance Q7A GMPs for API s Section XVI: Contract Manufacturers: there should be a written and approved contract or formal agreement between a company and its contractor that defines in details the responsibilities, including the quality measures, of each party. 12

EU Guidelines for GMPs Volume 4 Chapter 7: Outsourced Activities section 7.1 states there shall be a written contract covering the outsourced activities...

Pharmaceutical Inspection Convention Scheme (PIC/S) PE 009-11 (Part I) Guide on GMPs for Medicinal Products, March 2014 Chapter 7: Contract Manufacture and Analysis states there must be a written contract between the contract giver and the contract acceptor which clearly establishes the duties of each party.

International Pharmaceutical Excipients Council (IPEC) IPEC Guide for Quality Agreements, 2009 establishes best practices for Quality Agreements

ICH Q9 Risk Management recommends evaluation of suppliers and CMOs through audits and Quality Agreements.

Pop Quiz Are Quality Agreements subject to FDA review?

Quality Agreement Scope Terms (including effective date) Dispute resolution Change control Responsibilities and contacts

Quality Agreement Deviations Audits by owner and regulatory agencies Preventing cross-contamination Facilities and equipment validation

Quality Agreement Material management sampling, testing, quarantine, release, specifications, auditing & qualifying suppliers, storage, labeling Product specifications, release, expiration dating, batch numbering, storage, shipment

Quality Agreement Laboratory Controls procedures for sampling and testing, method validation, equipment maintenance and calibration, stability, and reserve samples OOS investigations.

Quality Agreement Record retention Field alerts and recalls Complaints and adverse event reporting Subcontractors Man-in-the-plant

Quality Agreement Owner Responsibility transfer of knowledge to review and approve SOPs, MBRs, specifications, lab records, validation documents(not all cases), annual reports, investigations, and change controls(not all cases).

Pop Quiz If a MBR approved by the owner contains a step that is non-gmp compliant, is the contractor responsible?

Answer Both owner and contractor are responsible.

Gospel According to Luke GMP Training Bi-lingual documents

Sample QAA

Thank You! You ve been a wonderful audience! Luke.foo@sppirx.com